Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer-Reference-Cited by-同舟云学术

Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer

Published:2015-06-04 Issue:8 Volume:56 Page:1239-1245
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Vassileva Vessela,Rajkumar Vineeth,Mazzantini Mario,Robson Mathew,Badar Adam,Sharma Surinder,Årstad Erik,Hochhauser Daniel,Lythgoe Mark F.,Boxer Geoffrey M.,Pedley Rosmund Barbara

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference31 articles.

1. Novel drug discovery opportunities for colorectal cancer

2. Cancer statistics, 2013

3. General overview of radioimmunotherapy of solid tumors

4. Technological Advances in Radioimmunotherapy

5. Clinical radioimmunotherapy—the role of radiobiology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p‐EGFR and p‐ERK;Thoracic Cancer;2023-06-20

2. Therapeutic Characterization of 131I-Labeled Humanized Anti-B7-H3 Antibodies for Radioimmunotherapy for Glioblastoma;Engineering;2023-06

3. Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer Efficacy;The AAPS Journal;2022-03-25

4. Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC);Cancers;2021-11-09

5. Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging;Biomedicines;2021-07-13